The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Dallas.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Remeditex Ventures, startups are often financed by Boulder Ventures, Amgen Ventures, Broadview Ventures. The meaningful sponsors for the fund in investment in the same round are Atlas Venture, Boulder Ventures, Amgen Ventures. In the next rounds fund is usually obtained by Boulder Ventures, Atlas Venture, Amgen Ventures.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Health Care, Biopharma. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Rodin Therapeutics, Bi02 Medical, Navitor Pharmaceuticals
The high activity for fund was in 2015. The fund is generally included in less than 2 deals every year. This Remeditex Ventures works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2019. The typical startup value when the investment from Remeditex Ventures is 100-500 millions dollars. The real fund results show that this VC is 8 percentage points more often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Related Funds
Funds with similar focus
Fund Name | Location |
Bihoop Ventures | Barcelona, Catalonia, Spain |
Block Dream Fund | - |
Defense.Net | Belmont, California, United States |
ESADE BAN | Barcelona, Catalonia, Spain |
Gauss Ventures | England, London, United Kingdom |
Octave Ventures | Canada, Ontario, Toronto |
Onevest | New York, New York, United States |
PNF venture capital | Luleå, Norrbottens Lan, Sweden |
Spearflower VC | - |
Thakral Group | Central Region, Singapore, Singapore |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Rodin Therapeutics | $27M | 18 Sep 2017 | Cambridge, Massachusetts, United States | ||
VYNE Therapeutics | $50M | 18 Jul 2017 | California, United States | ||
Navitor Pharmaceuticals | $33M | 18 Dec 2015 | Cambridge, Massachusetts, United States | ||
Viridian Therapeutics | $40M | 10 Nov 2015 | Boulder, Colorado, United States | ||
VYNE Therapeutics | $45M | 01 Nov 2015 | California, United States | ||
VYNE Therapeutics | $14M | 01 May 2015 | California, United States | ||
Viridian Therapeutics | $8M | 18 Feb 2015 | Boulder, Colorado, United States | ||
Viridian Therapeutics | $7M | 27 Jun 2014 | Boulder, Colorado, United States | ||
Bellicum Pharmaceuticals | $14M | 07 Jan 2014 | Houston, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Rodin Therapeutics | $27M | 18 Sep 2017 | Cambridge, Massachusetts, United States | ||
VYNE Therapeutics | $50M | 18 Jul 2017 | California, United States | ||
Navitor Pharmaceuticals | $33M | 18 Dec 2015 | Cambridge, Massachusetts, United States | ||
Viridian Therapeutics | $40M | 10 Nov 2015 | Boulder, Colorado, United States | ||
VYNE Therapeutics | $45M | 01 Nov 2015 | California, United States | ||
VYNE Therapeutics | $14M | 01 May 2015 | California, United States | ||
Viridian Therapeutics | $8M | 18 Feb 2015 | Boulder, Colorado, United States | ||
Viridian Therapeutics | $7M | 27 Jun 2014 | Boulder, Colorado, United States | ||
Bellicum Pharmaceuticals | $14M | 07 Jan 2014 | Houston, Texas, United States |